Regenerex Pharma (RGPX) Enterprise Value (2010 - 2025)

Regenerex Pharma (RGPX) has 14 years of Enterprise Value data on file, last reported at -$11659.0 in Q3 2025.

• Enterprise Value for Q3 2025 came in at -$11659.0, down 3865.65% year-over-year; the trailing twelve-month figure through Sep 2025 was -$11659.0 (down 3865.65% YoY), and the FY2025 annual result was -$653025.0, down 175444.35% from the prior year.
• Enterprise Value improved to -$11659.0 in Q3 2025 per RGPX's latest filing, from -$172430.0 in the prior quarter.
• Over five years, Enterprise Value peaked at -$294.0 in Q3 2024 and troughed at -$653025.0 in Q1 2025.
• A 5-year average of -$52515.4 and a median of -$2714.5 in 2021 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value jumped 95.7% in 2024, then sank 175444.35% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$2789.0 in 2021, then soared by 56.87% to -$1203.0 in 2022, then plunged by 553.03% to -$7856.0 in 2023, then jumped by 95.7% to -$338.0 in 2024, then slumped by 3349.41% to -$11659.0 in 2025.
• Business Quant data shows RGPX's Enterprise Value at -$11659.0 in Q3 2025, -$172430.0 in Q2 2025, and -$653025.0 in Q1 2025.